TY  - JOUR
AU  - Law, Zhe Kang
AU  - Desborough, Michael
AU  - Roberts, Ian
AU  - Al-Shahi Salman, Rustam
AU  - England, Timothy J
AU  - Werring, David J
AU  - Robinson, Thompson
AU  - Krishnan, Kailash
AU  - Dineen, Robert
AU  - Laska, Ann Charlotte
AU  - Peters, Nils
AU  - Egea-Guerrero, Juan Jose
AU  - Karlinski, Michal
AU  - Christensen, Hanne
AU  - Roffe, Christine
AU  - Bereczki, Daniel
AU  - Ozturk, Serefnur
AU  - Thanabalan, Jegan
AU  - Collins, Rónán
AU  - Beridze, Maia
AU  - Bath, Philip M
AU  - Sprigg, Nikola
PY  - 2021
DO  - 10.1161/JAHA.120.019130
UR  - http://hdl.handle.net/10668/17182
T2  - Journal of the American Heart Association
AB  - Background Antiplatelet therapy increases the risk of hematoma expansion in intracerebral hemorrhage (ICH) while the effect on functional outcome is uncertain. Methods and Results This is an exploratory analysis of the TICH-2 (Tranexamic Acid in...
LA  - en
KW  - antiplatelet
KW  - cerebral hemorrhage
KW  - hematoma expansion
KW  - randomized controlled trial
KW  - tranexamic acid
KW  - Aged
KW  - Antifibrinolytic Agents
KW  - Cerebral Hemorrhage
KW  - Disease Progression
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Male
KW  - Platelet Aggregation Inhibitors
KW  - Prognosis
KW  - Prospective Studies
KW  - Tranexamic Acid
TI  - Outcomes in Antiplatelet-Associated Intracerebral Hemorrhage in the TICH-2 Randomized Controlled Trial.
TY  - research article
VL  - 10
ER  -